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Abstract. We aimed to obtain and characterize (morphology, spectroscopy, viability) different 
types of microcapsules built with alginate or chitosan matrices which entrap Streptococcus 
thermophilus and Lactobacillus delbrueckii subsp. bulgaricus as probiotics. We used as matrices 
chitosan (CH) (1%, 1.5%, 2% w/v) and alginate (AG) (1%, 1.5%, 2% w/v) and the same percentage of 
probiotics (1mg/10ml matrix solution) to obtain microcapsules by coacervation. The concentration of 
AG and CH influenced the diameter, aspect, compactness of beads. Capsules of AG 1.5%, had the 
biggest area (4,1mm2) and diameter (2mm) while CH 2% had the smallest area (1.5 mm2) and 
diameter (2,1mm). As a complementary characterization the FTIR–HATR spectroscopy was able to 
fingerprint the free matrix, and encapsulated probiotics, identifying the specific markers located at 
900-1100 cm-1(carbohydrates), 1560-1620 cm-1 (for sugar ring stretching) and a large band (for water) 
at 3100-3700 cm-1.The fingerprint of encapsulated probiotic is recognised by 2 signals identified at 
2880 and 2920 cm-1. The most suitable matrices for probiotic encapsulation were established to be AG 
2%, AG 1.5%.The viability of probiotic powder in culture was 109 ml-1 while in capsules the viability 
was 10 6 ml-1 . We can notice that capsules with AG 1.5% and CH 1.5% released more bacteria and the 
viability was higher then in AG 2% and CH 2%, respectively.  
 




Probiotics are living microorganisms which transit the gastrointestinal tract and bring 
benefits to the health of the consumer (Tannock et al., 2000). Their therapeutic benefits 
induced the incorporation of probiotic bacteria (such as lactobacilli and bifidobacteria) in 
dairy products, especially yoghurts (Lourens-Hattingh et al., 2001). The efficiency of added 
probiotics depends on their level and their viability must be maintained throughout storage, 
increasing shelf-life and they must survive the gut environment (Kailasapathy et al., 2000). 
Hence viability of probiotics bacteria is of paramount importance in the marketability of 
probiotic-based food products. Several reports have shown that survival and viability of 
probiotic bacteria is often low in yoghurt (Dave et al., 1997; Gilliland et al., 1977; Hull et al., 
1984; Kailasapathy et al., 1997; Lourens- Hattingh et al., 2001; Schioppa, et al., 1981; Shah, 
2000; Shah et al., 1995) and results in less than 108–109 cells daily recommended intake 
(Lourens-Hattingh et al., 2001). A number of different brands of commercial yoghurts have 
been analysed in Australia (Anon, 1992; Shah, 2000; Shah et al., 1995) and in Europe (Iwana 
et al., 1993) for the adequate presence of L. acidophilus and Bifidobacteria. Most of the 
yoghurts contained very low numbers of these organisms, especially Bifidobacteria. 
Microencapsulation of bacterial cells is currently gaining attention to increase viability 
of probiotics bacteria in acidic products such as yoghurt (Godward et al., 2003; Kailasapathy, 
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2002; Krasaekoopt et al., 2003). We aimed to obtain and characterize (morphology, 
spectroscopy, viability) different types of microcapsules built with alginate or chitosan 
matrices which entrap Streptococcus thermophilus and Lactobacillus delbrueckii subsp. 
bulgaricus as probiotics.The viability of probiotics culture (like powder and from capsules) 
was also studied. 
 
MATERIALS AND METHODS 
 
Materials. Sodium alginate (AG) was purchased from Promova Biopolymer Norway, 
calcium Chloride (CaCl2), chitosan (CH) (medium molecular weight), natrium 
tripolyphosphate (NaTPP), acetic acid from Sigma Aldrich. Probiotic bacteria ( Streptococcus 
thermophilus and Lactobacillus delbrueckii subsp. bulgaricus) were purchased from MTC, 
Romania. 
Preparation of beeds. Concentrations of alginate (2%,1.5%,1% w/v) (AG) and 0.1 g 
probiotic bacteria were dissolved in 10 ml of deionised water. Chitosan in different 
concentration (2%,1.5%,1% w/v) (CH) and 0.1g of probiotic bacteria was dissolved in 10ml 
solution (9.93 ml  water and 0.07 ml acetic acid 0.7%).  The emulsion obtained, was 
homogenized and dropped, using a syringe with needle (0.4 x 20mm) into a hardening bath 
2% (w/v) solution of CaCl2 (for AG) and bath 5% (w/v) solution of NATPP (for CH) to 
obtain the probiotic capsules made of alginate and chitosan. After 30 minutes, the capsules 
were separated from the hardening baths by filtration. 
Beads Characterization: sizes and morphology. The obtained bead sizes, areas, 
perimeters, elongation and compactness were measured using the UTHSCSA ImageTool 
software. 
FTIR-HATR analysis. The FTIR spectra were obtained with a Schimatzu IR Prestige- 
21 with HATR and an internal reflection accessory made of Composite Zinc Selenide (ZnSe) 
and Diamond crystals. Each spectrum was registered from 4000-650 cm-1.The FTIR spectra 
were recorded for all samples in parallel with controls. 
Viability of probiotics bacteria. Aliquots of 1mg of probiotic culture were inoculated 
in 180 ml  MRS bullion. The MRS medium was skaked at 37°C, for 30hours. Aliquots were 
taken at 1h, 2h, 4h, 6h, 8h, 11h, 14h, 22h, 28h, 30h, diluted and inoculated on MRS agar (50 
µl*3), incubated for 48 hours at 30°C.The probiotic capsules were added to MRS bulion.  
 
RESULTS AND DISCUSSION 
 
Beads Characterization. By dropping into the hardening baths the emulsions of AG 
with probiotic bacteria we obtained beads with diameter of 1-3 mm and almost spherical 
shape. From the emulsion of CH with probiotic bacteria we obtained beads with diameters 
under 1mm, oval and irregular. The concentration of AG and CH influenced the diameter of 
beads; increasing concentration of matrices (from 1% to 2%) determined harder beads with 
higher diameter.  Fig.1 illustrates the differences between all probiotic capsules. Capsules 
diameter of CH 1% and AG 1% were less then 1mm and oval, while capsules of CH 1.5% and 




















Fig 1. Represents beads containing probiotic bacteria: AG 2%, b. AG 1.5%, AG 1%,  
CH 2%, CH 1.5%, CH 1%.The scale of capsules measurement is exposed in cm. 
 
In order to compare all the matrices and their concentrations used to obtain probiotic 
beads, (Fig.2), were measured their area, perimeter, elongation, roundness, diameter, 
compactness coefficient. Significant differences were observed especially in capsule area, 
perimeter and diameter. The most suitable for probiotic encapsulation were AG 2% and AG 
1.5%. Capsules of AG 1.5%, had the biggest area (4,1mm2) and diameter (2mm) while CH 
2% had the smallest area (1.5 mm2) and diameter (2,1mm). Roundness and compactness were 
nearly (1 mm) for all capsules. AG 1.5% had the largest perimeter (8 mm) while CH 2% had 
the lowest one (5 mm). Matrix with concentration of 1.5%, gives maximum water adsorption 
and area, diameter and perimeter was maximum. Capsules of AG are translucent, adsorbed 






















































       Fig 2. Comparative graphic representation of characteristics of AG 2%, AG 1.5%, AG 1%, CH 2%, CH 
1.5%, CH 1% 
 
FTIR –HATR analysis. The Comparative FTIR spectra of AG 2%, AG 1.5%, AG 1%, 
CH 2%, CH 1.5%, CH 1% matrices and probiotic capsules in AG 2%, AG 2%, AG 1.5%, AG 
1%, CH 2%, CH 1.5%, CH 1% are plotted  in Fig 3. The wavenumbers useful for matrices 
AG  1% AG 1.5% AG 2% 
CH 1% CH 1.5% CH 2% 
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discriminations were identified at 3244-3302 cm-1 (O-H stretch), 1400-1474 cm-1 (CH2 
bending), 1000-1200 cm -1 (C-O and C-C stretch), 924-1000 cm-1 (poly OH and CH2 twist), 
776-892 cm-1(glycoside links) ( Socaciu, 2009;Trif et al., 2007). 
 The alginate FTIR spectrum (Fig.3a) contains the characteristic peaks at 3242 cm−1 
(OH− stretching) as mentioned before Lawrie, 2007, 1596 and 1407 cm−1 (COO− asymmetric 
and symmetric stretching), 1081-1024 cm−1 (C-O-C antisymmetric stretching), and carboxyl 
and carboxylate at about 1000 to 1400 cm−1 (Mayur, 2005). 
 In Fig 3 and Fig 4, are shown the wavenumbers characteristic considered for both 
matrices, located at 900-1100 cm-1(carbohydrates) (1), 1560-1620 cm-1(sugar ring stretching) 
(2) and a large band due to water 3100-3700 cm-1(4). The encapsulated probiotic is recognised 
only by the group of 2 signals (3) identified at 2880 and 2920 cm-1 which correspond to same 
signals identified in pure probiotic culture (Fig 4).No differences were observed between the 

















Fig. 3 Comparative FTIR fingerprint of matrices and capsules with probiotic bacteria of a: AG 2%, AG 1.5%, 
AG 1%,and b: CH 2%, CH 1.5%, CH 1%. (1)– carbohydrates; (2) - sugar ring stretching; (3) - bacterial 
fingerprint; (4) - water. 
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Fig. 4. Comparative FTIR fingerprint of:  probiotic capsules AG 1.5%, matrices of AG 1.5%, and probiotic 
culture (1mg/10 ml water) 
 
Viability of probiotics bacteria. Fig 5. represents the viability curve of probiotic 
bacteria (Streptococcus thermophilus and Lactobacillus delbrueckii subsp. Bulgaricus) on 
powder ( )(max. 14 C.F.U*109 ml-1) used for encapsulation and the viability of probiotic 
capsules of CH 1.5% ( )( max.12 C.F.U*106 ml-1), CH 2% ( ) (max. 8 C.F.U*106 ml-
1), AG 1.5% ( )( max.15 C.F.U*106 ml-1), AG 2% ( )(max. 14 C.F.U*106 ml-1). Thus, 
it can be noted that capsules with AG 1.5% and CH 1.5% released more bacteria with a higher 

































































Fig.5. Comparative probiotic viability after release in media MRS bullion and cultivation on MRS agar:  
probiotic powder, and capsules with probiotic bacteria of:   CH 1.5%, 







































The most suitable matrices for probiotic encapsulation with Streptococcus 
thermophilus and Lactobacillus delbrueckii subsp. Bulgaricus were alginate (AG 2% and AG 
1.5%), considering their morphology and viability. FTIR fingerprint of encapsulated probiotic 
is recognised by the specific group of 2 signals identified at 2880 and 2920 cm-1 and 
represents an useful way to investigate non-destructively, such capsules. The probiotic 
viability of  probiotic powder was superior (109 ml-1) then for probiotic capsules (106 ml-1). 
Thus, it can be noted that capsules with AG 1.5% and CH 1.5% released more bacteria with a 
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